Nina Ma Email & Phone Number

- Led the Global Medical Affairs strategy for developing scientific and medical alliances within the early cancer ecosystem to support the strategic objectives of the Early Detection Business Unit- Coordinated cross-functional collaboration with Research & Development (R&D), External Innovation, and other teams to drive clinical studies and initiatives.- Strategized and implemented a comprehensive data generation plan derived from thorough clinical data gap analysis, prioritizing key areas for research and development.- Successfully acquired and managed Investigator Initiated Studies (IISs), overseeing the review process in compliance with local laws and regulations. Maintained proactive engagement with investigators to ensure seamless execution.- Orchestrated diverse medical activities encompassing both internal and external scientific product presentations. Led and participated in advisory boards to gain invaluable insights, crucial for refining Medical Affairs strategies and tactics.- Devised a robust Key Opinion Leader (KOL) engagement plan, fostering the identification, cultivation, and nurturing of strategic relationships with KOLs to bolster medical objectives and initiatives.

Singapore, Singapore

• Developed the local therapeutic area strategy by engaging all stakeholders directly touching the patient journey (in a given disease area), gained a deep understanding of their needs in order to connect company’s capabilities (current and future) to co-create meaningful solutions. • Led the implementation of overall local therapeutic area strategy to foster top tier scientific KOL relationships, and to build appropriate advocacy and engagement in line with organization’s objectives.• Deployed resources required to drive solutions to improve outcomes for patients, their community, the ecosystem and the organization.• Ensured effective and up-to-date communication of therapy area advancements and scientific data through external engagements which can help guide pipeline development and service provision to benefit the customers and patients as well as supporting internal stakeholders.• Laid a strong foundation to strengthen Singapore’s footprint as a leader in the given disease area (HCC) across APAC (inc. China) by constantly providing opportunities and support to our KOLs for them to get exposure at the international platform (e.g. publication, global studies collaboration and medical education webinars).• Fostered close collaboration with APAC countries to develop a series of platform-based educational content for KOLs in discussion format; to provide information that will simplify and improve physician (and patient) lives, and to explore clinical practice.• Initiated effort to expand the clinical benefit of existing innovations through generation of compelling scientific evidence in partnership with top local/global KOLs through clinical studies (e.g. investigator initiated studies, sponsored clinical trials).

Singapore, Singapore

• Developed and led the execution of KOL engagement plans to gather data and key insights to inform strategic decision making of the Hepatocellular Carcinoma (HCC) squad.• Worked closely with medical manager to drive various strategic initiatives (e.g. evidence generation for disease area of interest and scientific publications).• Addressed HCPs concerns and collaborated with them to co-create various CME activities, many of which have had tangible positive impact on our regional affiliates (e.g. HCC Expert Digital Learning series with Singapore Hepatology Conference, HCC Masterclass with Singapore Society of Oncology, APAC Post ASCO GI 2021 fireside chat webinar and newsletter, Asia Pacific Gastroenterology Cancer Summit (APGCS) 2021.• Spearheaded multi-country collaboration project. Played a pivotal role from conceptualization to execution. • Worked closely with internal and external stakeholders to build a thorough understanding of the market, customers’ needs, attitudes, drivers and behaviours with the aim of sharing the merit of company’s portfolio, whenever possible.• Opened up new opportunities to engage new external stakeholders and developed plans that drive co-creation projects across different business units (Pharmaceutical and Diagnostics).• Brought value to the network and the healthcare ecosystem across APAC affiliates by providing support and advice pertaining to HCC patient journey and management.• Unlocked possibility to deliver value to patients and the APAC community through the delivery of HCC patient story video.

Singapore

• Independently managed multiple studies across different therapeutic areas (e.g. liver cancer, breast cancer, lung cancer, renal/kidney disease, Alzheimer’s disease, and infectious disease) from study start-up, recruitment, and maintenance till study closure.• Fostered strategic partnership with relevant stakeholders in the ecosystem to ensure efficient study start-up timeline which in turn leads to greater access of innovations for patients.• Collaborated closely with the local health authority (HSA) to implement new guidelines on study consents- the first time for HSA to have such incidence.• Regarded as the Partner of Choice by investigators/institutions in clinical trials. Laid a strong foundation for our KOLs to be involved in publication in collaboration with our global team through clinical trial.• Taken prompt action to convince global study team to conduct “important priority” studies in Singapore to ensure access to local patients.• Coordinated site contract reviews and service agreement setup between relevant stakeholders with the aim to drive efficiency and reduction of timeline across start up and contract negotiation.• Proactively shared studies insights and delivered knowledge across the organization to drive cross-functional collaboration.

• Evaluated the interaction of three dimensional model and extracellular matrix in reprogramming and promotion of stemness, which led to a publication in a high-impact journal• Identified the contribution of microenvironment in affecting the clinical outcome of glioblastoma. • Planned and executed a broad range of molecular biology and biochemistry experiments to ensure the results were delivered accurately• Coordinated work across departments to ensure maximum efficiency and progress of research projects• Served as an effective representative/spokesperson for the organization to the internal and external parties – Scientific Advisory Board (SAB) and the public• Represented company in X-periment! - a Science exhibition organized by the Science Centre for the public• Mentored students from various schools (e.g. Nanyang Girls’ High School, Raffles Girls' School, Victoria Junior College and National University of Singapore) for scientific projects

Singapore

• Synthesized and characterized novel ultrashort peptide candidates developed by Dr Hauser et al. to enhance their ability to support the growth of adult stem cells• Functionalized peptide hydrogels with bioactive moieties such that the resulting composite hydrogels can be used as biomaterial for tissue engineering and regenerative medicine

Singapore

• Developed DNA-based biosensors for rapid identification of pathogens• Utilized DNA as nanowires and produced dual-labeled DNA nanowires by optimizing PCR parameters• Planned and executed a broad range of technical tasks to ensure the project and respective results were delivered on time and accurately• Proposed the possible explanations for the results observed and recommended the next steps

Singapore

• Increased production of Baculovirus for clinical trial• Produced recombinant viral expression vectors using BacPAK6 DNA• Performed plaque assay and cell culture • Performed PCR and RT-PCR

• Identified customers’ needs and expectations and strove to provide excellent customer service.• Promoted store and products by answering customers’ enquiries and resolving complaints. • Developed excellent rapport with customers.

Mount Elizabeth Hospital

• Maintained accurate drug inventory records to ensure a reliable supply of medicine.• Performed electrocardiogram (ECG) procedure on patients.• Dispensed prescription medications to the patients and offered advice on their safe use.• Re-organized data handling procedure in the clinic, increased productivity by 10%.

Temasek Polytechnic

• Designed and built multi-parameter monitoring device to monitor the environmental factors of an animal rack used in animal research facilities. A total of six parameters (temperature, relative humidity, noise, light intensity, carbon dioxide and ammonia gas) were successfully measured, displayed and stored in the SD card• Initiated implementation of a new product design to meet the users’ needs• Performed analytical testing, data management and equipment maintenance• Carried out programming and debugging of source code using C language• Communicated results to supervisor, project members, collaboration partners and higher levels of management• Worked independently as well as in a team, across disciplines, functions, and with external stakeholders to deliver the project on time and accurately

Master Of Business Administration - Mba, Mba, Honors (Top 10% Of The Cohort)

Bachelor Of Science (Honours) In Biological Sciences, Biological And Biomedical Sciences, First Class Honours

Activities and Societies: NTU Welfare Services Club, First Youth Olympic Games (YOG) Volunteer as Airport Operation Officer, Service.

Diploma (With Merit) In Biomedical Informatics & Engineering, Biomedical Informatics & Engineering, 4.0/4.0

Activities and Societies: Vice President of the Diploma Bioengineering Studies Club, Student Ambassador of Temasek Engineering School.